Ultrasound-guided heat treatment of knee nerves for osteoarthritis knee pain
Tests genicular nerve radiofrequency ablation in adults with long-lasting osteoarthritis knee pain.
Key facts
- Who runs it
- Centro Hospitalar Universitario do Algarve
- Where
- Portugal2 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Revised Targets for Knee Radiofrequency Ablation
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 20 Mar 2025
- Expected to end
- 30 Jul 2031
- Type of study
- Observational
- Treatments tested
- Ultrasound-Guided Genicular Nerve Radiofrequency Ablation
- Record updated
- 24 April 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with long-term knee pain from knee osteoarthritis (joint wear) that other treatments did not help. Each person gets one heat treatment of the knee nerves, guided by ultrasound.
- Age
- 18 Years and older
- Sex
- All sexes can join.
- Disease stage
- Knee osteoarthritis seen on X-ray, Kellgren-Lawrence grade III or IV (moderate to severe), with chronic knee pain.
- Earlier treatment
- Pain and limited movement must remain after knee physiotherapy and pain medicine (such as paracetamol or anti-inflammatory drugs). They must also remain after steroid injections into the knee, or these must have helped only a little. People who already had radiofrequency ablation or a knee replacement cannot join.
Main reasons for not taking part
- Previous knee replacement surgery or earlier radiofrequency ablation
- Pacemaker
- Metal implants from bone surgery in or near the knee
- Widespread pain or nociplastic pain (pain from a changed pain system)
- Serious mental or emotional disorders, or addictive behaviors
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Patients with chronic knee pain related to radiographic knee osteoarthritis, Kellgren-Lawrence (KL) grade III or IV, who are refractory to conservative treatment; (Refractoriness to conservative treatment is defined as:
- Persistent pain and functional limitation after undergoing knee-targeted physiotherapy and analgesic medication in accordance with clinical guidelines for osteoarthritis [e.g., paracetamol, nonsteroidal anti-inflammatory drugs, and other drugs as deemed appropriate by the treating physician]
- Persistent pain and functional limitation after intra-articular corticosteroid injections or limited success with such interventions.)
Who cannot take part
- Patients with previous knee arthroplasty
- Patients who have undergone prior radiofrequency (RF) ablation
- Significant psycho-emotional disorders
- Addictive behaviors
- Generalized pain
- Nociplastic pain
- Presence of a pacemaker
- Presence of osteosynthesis material in the knee or adjacent anatomical regions
This trial is currently available in Portugal.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This research team is doing a study to learn more about a new way to treat long-term knee pain caused by joint damage. They are using a treatment called radiofrequency ablation (RFA). This is a procedure where doctors use heat to stop certain nerves from sending pain signals.
Read full original descriptionShow less
In this study, doctors will use ultrasound to guide a small needle to nerves around the knee, called genicular nerves. Then, they will apply heat to those nerves using radiofrequency energy to help reduce pain.
The team created this new method based on recent studies of knee anatomy. They want to find out if this method can safely reduce pain and help people with knee joint damage move better. The study includes people who have moderate to severe knee damage and still have pain after trying medicine, physical therapy, or joint injections.
Each person in the study will have the treatment once. The research team will follow each person for two years. During this time, people in the study will answer simple questions about their knee pain and how it affects their daily life. The researchers will collect this information before the treatment and several times after it. One week after the procedure, the team will call each person to ask how they are feeling and check for any side effects.
Possible benefits of the study include less knee pain and easier movement. Possible risks include pain during the procedure, bruising, swelling, or short-term worsening of pain. Rare risks include nerve problems, weakness, bone damage, or allergic reaction.
The study is free for participants, and there is no payment. Taking part is voluntary. Anyone can stop being in the study at any time without affecting their medical care. The research team will keep all personal information private and secure.
The group in the trial
- Single-Session Ultrasound-Guided Genicular Nerve Radiofrequency Ablation in Patients With Knee Osteo
Participants with knee osteoarthrosis (Kellgran-Lawrence III or IV) will receive a single-session ultrasound-guided radiofrequency ablation of the genicular nerves. The procedure targets three specific nerve branches around the knee joint: the superomedial, superolateral, and inferomedial genicular nerves. The targeted positions are based on anatomical reference points described by Fonkoue et al. (2021) and validated in cadaveric studies, aiming to improve the accuracy of nerve localization. Under ultrasound guidance, the clinician will insert a radiofrequency needle at each target site. After confirming correct positioning through sensory and motor stimulation, thermal ablation will be performed at 85ºC for 90 seconds per site. Local anesthesia will be administered before each ablation to ensure patient comfort. This procedure aims to reduce knee pain and improve function in patients with moderate to severe knee joint degeneration who have not responded to conservative treatments.
Treatment: Ultrasound-Guided Genicular Nerve Radiofrequency Ablation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Segurança e eficácia de Nova Abordagem Ecoguiada de ablação Por radiofrequência Dos Nervos Geniculados
- Plain-language title
- Ultrasound-guided heat treatment of knee nerves for osteoarthritis knee painGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 24 April 2025